Endometriosis Trial, Recruiting NCT07393295 Sponsor: Monath Electronic Condition: Endometriosis
Back to Endometriosis

Endometriosis Trial, Recruiting

NCT07393295
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are a woman aged 18 or older
  • You have been diagnosed with endometriosis and/or adenomyosis through a scan or tissue test
  • You have been on the same hormone treatment (which has stopped your periods) continuously for at least 2 months
  • You are not planning to change your hormone treatment during the study
  • You have had ongoing pelvic pain for more than 6 months
  • Your pelvic pain is at least "moderate" on a scale from none to severe
  • You are willing to take part in the study
  • You agree to only use certain approved pain relief medications during the study (paracetamol, Acupan®, and Antadys®)
  • You have access to a computer, tablet, or mobile phone with an internet connection
  • You are covered by a social security or health insurance system

Who may not be able to join:

  • You are pregnant or breastfeeding
  • You have gone through menopause
  • Your endometriosis symptoms have gotten significantly worse in the last 28 days (confirm with trial site)
  • You have reduced skin sensitivity in the area where the study device would be applied
  • You have a known skin allergy to gel or electrode pads
  • You have a skin condition in the area where the device would be placed
  • You have a pacemaker or other active implanted medical device
  • You have epilepsy
  • You currently have a blood clot condition (thrombophlebitis or arterial thrombosis)
  • You have cancer with a life expectancy of less than 12 months
  • You have issues with alcohol or drug addiction
  • You have fibromyalgia
  • You have previously tried TENS therapy (a type of electrical nerve stimulation for pain)
  • You are not able to communicate fluently in English
  • You have cognitive impairments that affect understanding or memory
  • You have a severe, untreated psychiatric or psychological condition that is considered the main cause of your symptoms
  • You are currently taking part in another intervention study that could affect the results of this one
  • You have been taking high doses of opioid-based painkillers (more than 90 morphine equivalents per day) at least once in the last 28 days
  • You have gynaecological or endometriosis surgery planned in the next 3 months
  • You have had endometriosis surgery within the last 6 months
  • You have had your uterus removed (hysterectomy) or both ovaries removed (bilateral oophorectomy)
  • You are under legal guardianship or have had your personal freedoms restricted by law

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Bejamin MERLOT, IFEM Endo, Clinique Tivoli-Ducos, 5 rue Auguste Poirson, 33000 Bordeaux, France

Phone: +33-389497361

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Monath Electronic
Registry
ClinicalTrials.gov
Start date
15 March 2026
Est. completion
15 June 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Change in the mean value of average pain

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov